Search

Your search keyword '"Gaeta, G."' showing total 58 results

Search Constraints

Start Over You searched for: Author "Gaeta, G." Remove constraint Author: "Gaeta, G." Topic medicine Remove constraint Topic: medicine
58 results on '"Gaeta, G."'

Search Results

1. Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C

2. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

3. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

4. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

5. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients

6. HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study

7. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

8. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

9. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

10. Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis

11. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

12. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

13. Real life experiences in HCV management in 2018

14. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

15. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

16. Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

17. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel

18. From current status to optimization of HCV treatment: Recommendations from an expert panel

19. HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

20. Changing indications for liver transplant: slow decline of hepatitis viruses in Italy

21. Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study

22. Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis

23. Prenatal Management of Congenital Human Cytomegalovirus Infection in Seropositive Pregnant Patients Treated with Azathioprine

24. Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV

25. Uterine artery Doppler in singleton pregnancies conceived after in-vitro fertilization or intracytoplasmic sperm injection with fresh vs frozen blastocyst transfer: longitudinal cohort study

26. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review

27. Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group

28. AISF position paper on HCV in immunocompromised patients

29. Hepatitis c late relapse in patients with directly acting antiviral- related sustained virological response at week 12

30. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

31. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience

32. Treatment of acute hepatitis C: recommendations from an expert panel of the Italian Society of Infectious and Tropical Diseases

33. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

34. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

35. Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP)

36. Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort

37. Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT)

38. Etiological factors of chronic hepatitis in Italy: a 2014 national survey

39. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

40. Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study

41. Hepatitis delta infection in Italian patients: towards the end of the story?

42. Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort

43. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

44. AISF position paper on liver disease and pregnancy

45. Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology

46. DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation

47. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

48. Prevalence and clinical outcome of hepatitis Delta infection in patients with HIV/HBV coinfection

49. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

50. Intermediate and Advanced Hepatocellular Carcinoma Management in four Italian Centers: Patterns of Treatment and Costs

Catalog

Books, media, physical & digital resources